Publication | Closed Access
Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Rasagiline: A Potent, Selective, and Irreversible Monoamine Oxidase Type B Inhibitor
96
Citations
25
References
2004
Year
Rasagiline is well tolerated at doses up to 20 mg once/day and is a potent inhibitor of platelet MAO-B in humans.
| Year | Citations | |
|---|---|---|
Page 1
Page 1